BMY

Beware! 3 Healthcare Stocks Waving Massive Red Flags Right Now.

By Alex Sirois, InvestorPlace Contributor
These three healthcare stocks to sell are waving red flags at investors who should pay attention or suffer the consequences.

The 3 Best Pharma Stocks to Buy Now: September 2023

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor
There are pharma stocks to buy for each type of investor. This article explores the best options in the industry.

Biotech Breakthroughs: 3 Companies on the Cusp of Major Discoveries

By Larry Ramer, InvestorPlace Contributor
Long-term investors looking for biotech stocks well-positioned to be lifted by major discoveries should pick firms that utilize AI. 

3 Sorry Pharma Stocks to Sell in August Before It’s Too Late

By Tyrik Torres, InvestorPlace Contributor
Factors in the marketplace caused these companies to underperform, making them some of the top pharma stocks to sell.

Looking for a Bargain? 7 Blue-Chip Stocks to Buy That Are Down 5% in 2023

By Muslim Farooque, InvestorPlace Contributor
These discounted blue-chip stocks boast robust underlying businesses which present amazing long-term upside potential ahead

The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023

By Charles Munyi, InvestorPlace Contributor
Trading below a 15 forward price-to-earnings, these undervalued pharma stocks offer opportunities in an overbought market.

Why Is Allarity Therapeutics (ALLR) Stock Up 30% Today?

By Josh Enomoto, InvestorPlace Contributor
Allarity Therapeutics became the toast of Wall Street Wednesday with positive early clinical data, though ALLR stock remains risky.

7 Healthcare Stocks to Make You the Millionaire Next Door

By Larry Ramer, InvestorPlace Contributor
For investors who want to greatly increase their wealth in the long term, these are the best healthcare stocks to buy. 

3 AI Stocks That Could Skyrocket Your Wealth

By Larry Ramer, InvestorPlace Contributor
AI is poised to greatly increase the top and bottom lines of many companies, making many AI stocks very attractive at this point. 

7 Dividend Stocks to Buy During a Market Downturn

By Chris Markoch, InvestorPlace Contributor
If you are still in search of total returns in this down market, then looking for dividend stocks to buy is a smart strategy for your portfolio.

7 Dividend-Paying Large-Cap Stocks to Buy in January

By Thomas Niel, InvestorPlace Contributor
Now's the time to load up on these seven dividend-paying large-cap stocks, each of which has a forward dividend yield of at least 3%.

5 Top Pharma Stocks of 2022 to Buy for the Long Haul

By Dana Blankenhorn, InvestorPlace Contributor
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.

7 Top-Rated Large-Cap Stocks to Buy and Hold

By Louis Navellier and the InvestorPlace Research Staff
Large-cap stocks are always great to have in a portfolio. These companies are the biggest – and some of the best-known – stocks in the stock market. That makes finding the best large-cap stocks a worthy exercise.

The 7 Best Pharma Stocks to Buy Now

By Joel Baglole, InvestorPlace Contributor
Oil and natural gas stocks are not the only ones to post big gains this year. Several pharmaceutical stocks have rallied 30% or more as sales of their blockbuster medications, including Covid-19 vaccines, supercharge their earnings.

The 7 Most Undervalued Value Stocks to Buy Now

By Alex Sirois, InvestorPlace Contributor
Undervalued value stocks remain available even as investors have pivoted toward low-valuation stocks in a volatile year for markets.

Best Stocks 2022: Why Bristol-Myers Squibb (BMY) Stock Is a Clear Winner

By Sure Dividend
There's a reason BMY stock is currently winning our Best Stocks for 2022 contest. Investors should buy BMY for value, safety and dividends.

7 Screaming Buy Stock Picks to Beat the September Market Slump

By Chris Lau, InvestorPlace Contributor
Savvy investors will take advantage of the stock market weakness and panic selling to accumulate discounted screaming buys.

Biotech Stocks Stand to Benefit as Biden Announces Support for Industry

By Samuel O'Brient, InvestorPlace Reporter
President Biden has announced a new initiative to help U.S. biotech producers grow. Here's what this news means for biotech stocks.

Bristol-Myers Squibb (BMY) Stock Jumps 8% as FDA Approves Psoriasis Treatment

By Dana Blankenhorn, InvestorPlace Contributor
Sotyktu's Phase 3 study showed it more effective than Amgen's Otezla for treating psoriasis.
Load More